Mortality comparison between axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SND) among breast cancer pantient: A meta-analysis and systematic review study

Pub Date : 2024-03-04 DOI:10.15562/bmj.v13i1.5265
Alifia Ramadhani Herida, Sari Puspita Dewi, Akmal Fauzan Herida
{"title":"Mortality comparison between axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SND) among breast cancer pantient: A meta-analysis and systematic review study","authors":"Alifia Ramadhani Herida, Sari Puspita Dewi, Akmal Fauzan Herida","doi":"10.15562/bmj.v13i1.5265","DOIUrl":null,"url":null,"abstract":"Introduction: Axillary lymph node dissection (ALND) is a crucial surgical procedure for breast cancer. It has guaranteed locoregional control of the disease, guided adjuvant therapy, and functioned as a staging tool. However, over the past 25 years, a more conservative approach has become the standard for surgical management of the axilla. Because sentinel lymph node biopsy (SNB) is less invasive and less morbid than axillary lymph node dissection (ALND), it has become the standard surgical procedure for axillary staging of clinically node-negative breast cancer. This study aimed to compare the mortality of breast cancer patients receiving ALND and SNB procedure.\nMethods: Our review includes randomized controlled trials of breast cancer patients undergoing ALND or SNB surgical techniques. A systematic literature search was performed from PubMed on December 2023 to search for articles reporting on survival rates between ALND vs SNB among breast cancer patients. The data obtained then underwent statistical evaluation, and a meta-analysis was conducted using Review Manager 5.4. In order to represent primary outcomes, the risk ratio was estimated using an inverse variance technique with a random-effects model. Heterogeneity was presented with total values, 95% confidence intervals (CI), and I values.\nResults: As many as 208 articles were found in the PubMed database search, and only six studies were included in this study. The six included trials all used chemotherapy and radiotherapy for systematic treatment. The length of follow-up varied from 33 months to 15 years. The total number of patients in the trials was 3,585, and the study period was from 2011 to 2023. The pooled analysis of the mortality outcomes showed that the heterogeneity of the data was low (I2 21%, p = 0.4). In the pooled analysis, the mortality of patients with SNB for surgical treatment was not significantly different compared to patients with ALND (OR:0.88; 95% CI:0.65-1.19).\nConclusion: The mortality of patients undergoing SNB and ALND does not differ significantly, according to this pooled study. It demonstrates that the group without axillary dissection had a primary survival outcome that was not inferior to that of the dissection group.","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15562/bmj.v13i1.5265","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Axillary lymph node dissection (ALND) is a crucial surgical procedure for breast cancer. It has guaranteed locoregional control of the disease, guided adjuvant therapy, and functioned as a staging tool. However, over the past 25 years, a more conservative approach has become the standard for surgical management of the axilla. Because sentinel lymph node biopsy (SNB) is less invasive and less morbid than axillary lymph node dissection (ALND), it has become the standard surgical procedure for axillary staging of clinically node-negative breast cancer. This study aimed to compare the mortality of breast cancer patients receiving ALND and SNB procedure. Methods: Our review includes randomized controlled trials of breast cancer patients undergoing ALND or SNB surgical techniques. A systematic literature search was performed from PubMed on December 2023 to search for articles reporting on survival rates between ALND vs SNB among breast cancer patients. The data obtained then underwent statistical evaluation, and a meta-analysis was conducted using Review Manager 5.4. In order to represent primary outcomes, the risk ratio was estimated using an inverse variance technique with a random-effects model. Heterogeneity was presented with total values, 95% confidence intervals (CI), and I values. Results: As many as 208 articles were found in the PubMed database search, and only six studies were included in this study. The six included trials all used chemotherapy and radiotherapy for systematic treatment. The length of follow-up varied from 33 months to 15 years. The total number of patients in the trials was 3,585, and the study period was from 2011 to 2023. The pooled analysis of the mortality outcomes showed that the heterogeneity of the data was low (I2 21%, p = 0.4). In the pooled analysis, the mortality of patients with SNB for surgical treatment was not significantly different compared to patients with ALND (OR:0.88; 95% CI:0.65-1.19). Conclusion: The mortality of patients undergoing SNB and ALND does not differ significantly, according to this pooled study. It demonstrates that the group without axillary dissection had a primary survival outcome that was not inferior to that of the dissection group.
分享
查看原文
腋窝淋巴结清扫术(ALND)与前哨淋巴结活检术(SND)在乳腺癌患者中的死亡率比较:荟萃分析和系统综述研究
简介腋窝淋巴结清扫术(ALND)是乳腺癌的重要外科手术。它保证了疾病的局部控制,指导辅助治疗,并起到分期工具的作用。然而,在过去的25年中,更为保守的方法已成为腋窝手术治疗的标准。与腋窝淋巴结清扫术(ALND)相比,前哨淋巴结活检术(SNB)创伤更小、发病率更低,因此已成为临床结节阴性乳腺癌腋窝分期的标准手术方法。本研究旨在比较接受 ALND 和 SNB 手术的乳腺癌患者的死亡率:方法:我们的综述包括乳腺癌患者接受 ALND 或 SNB 手术技术的随机对照试验。2023年12月,我们在PubMed上进行了系统性文献检索,以搜索有关乳腺癌患者ALND与SNB生存率的报道。然后对获得的数据进行统计评估,并使用 Review Manager 5.4 进行荟萃分析。为了表示主要结果,使用反方差技术和随机效应模型估算风险比。异质性用总值、95%置信区间(CI)和I值表示:在 PubMed 数据库中搜索到多达 208 篇文章,只有六项研究被纳入本研究。所纳入的六项试验均采用化疗和放疗进行系统治疗。随访时间从 33 个月到 15 年不等。试验中的患者总数为3,585人,研究时间为2011年至2023年。死亡率结果的汇总分析显示,数据的异质性较低(I2 21%,P = 0.4)。在汇总分析中,接受SNB手术治疗的患者死亡率与接受ALND手术治疗的患者死亡率相比没有显著差异(OR:0.88; 95% CI:0.65-1.19):结论:根据这项汇总研究,接受腋窝淋巴结清扫术和腋窝淋巴结清扫术的患者死亡率没有明显差异。结论:根据这项汇总研究,接受SNB和ALND手术的患者死亡率并无明显差异,这表明未进行腋窝解剖组的主要生存结果并不亚于解剖组。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信